This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nalleli Fernandez, Center, With Her Family At CURE Honduras, San Pedro Sula, Honduras, On Sept. 18, 2012. Photo Is Courtesy Of CURE International.

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, recently donated several BioSet® RT Allograft Paste implants to Lemoyne, Pa.-based CURE International. The paste, a demineralized bone matrix (DBM), was used Sept. 18 during a surgery to remove a large, benign cyst from the pelvic bone of an 11-year-old patient in San Pedro Sula, Honduras.
Nalleli Fernandez, center, with her family at CURE Honduras, San Pedro Sula, Honduras, on Sept. 18,  ...

Nalleli Fernandez, center, with her family at CURE Honduras, San Pedro Sula, Honduras, on Sept. 18, 2012. Photo is courtesy of CURE International.

According to Ted Beemer, M.D., medical administrator/surgeon for CURE Honduras, the cyst extended from the front of the patient’s pelvic bone to her sacroiliac joint and caused extreme pain, presumably due to the weakening bone directly over the hip joint and adjacent to the sacroliliac joint. The patient was confined to walking with crutches for two months leading up to the surgery due to pain and fear of further collapse of the bone around the hip joint. The donated allograft paste was needed because obtaining sufficient autograft — tissue from one’s own body — risked weakening the side used for walking during the surgery recovery period.

“The surgery went well, and I fully expect her to make a complete recovery thanks to the substantial allograft donation by RTI,” Beemer said. “I am certain that her recovery would have been significantly deterred if we had needed to take that much autologous bone from her other side and/or lower extremities. In fact, she would have been confined to a wheelchair for weeks instead of being able to walk with crutches.

“We are very appreciative to RTI Biologics for its donation. It made a huge difference in this child’s treatment and will continue to affect her recuperation.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs